Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Allogene Therapeutics, Inc.
IPO Date: October 8, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $277.79M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.46 | 3.12%
Avg Daily Range (30 D): $0.06 | 4.79%
Avg Daily Range (90 D): $0.08 | 4.84%
Institutional Daily Volume
Avg Daily Volume: 1.45M
Avg Daily Volume (30 D): 3.28M
Avg Daily Volume (90 D): 4.34M
Trade Size
Avg Trade Size (Sh.): 133
Avg Trade Size (Sh.) (30 D): 358
Avg Trade Size (Sh.) (90 D): 296
Institutional Trades
Total Inst.Trades: 2,887
Avg Inst. Trade: $1.87M
Avg Inst. Trade (30 D): $1.39M
Avg Inst. Trade (90 D): $1.27M
Avg Inst. Trade Volume: .17M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.45M
Avg Closing Trade (30 D): $1.06M
Avg Closing Trade (90 D): $1.98M
Avg Closing Volume: 229.17K
   
News
Jun 1, 2025 @ 2:45 PM
Allogene Therapeutics Provides Updated Phase 1 Dat...
Source: N/A
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
Dec 26, 2024 @ 4:26 PM
Oncology in Focus: How Emerging Therapies Are Resh...
Source: Prnewswire
Oct 22, 2024 @ 5:00 PM
Gene Therapy Clinical Trial Pipeline Gains Momentu...
Source: Delveinsight
Sep 10, 2024 @ 8:51 AM
Gene Editing Therapeutics Market Forecast 2024-202...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-1.23 $-.28 $-.28
Diluted EPS $-1.23 $-.28 $-.28
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -252.32M $ -59.73M $ -59.94M
Operating Income / Loss $ -268.89M $ -65.19M $ -60.49M
Cost of Revenue $ $ $
Net Cash Flow $ -8.58M $ -32.76M $ 23.98M
PE Ratio